| Mrs Meghan June Cleary, MSW, LCSW-C | |
|
813-1 Chesapeake Drive, Cambridge, MD 21613-1835 | |
| (410) 221-2266 | |
| (410) 221-2878 |
| Full Name | Mrs Meghan June Cleary |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 22 Years |
| Location | 813-1 Chesapeake Drive, Cambridge, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013098961 | NPI | - | NPPES |
| 829621000 | Other | MD | MAGELLAN |
| KBM964798201 | Other | MD | BCBS |
| 479302100 | Medicaid | MD | |
| F7930012 | Other | MD | BCBS FEDERAL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 12591 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Marshy Hope Family Services, Llc | 6800840703 | 8 |
News Archive
Women are more sensitive to the effects of cocaine and more susceptible to cocaine abuse than men. Cocaine's ability to disrupt a woman's estrus cycle may explain the sex differences in cocaine addiction, and new evidence that caffeine may be neuroprotective and able to block cocaine's direct effects on the estrus cycle reveals novel treatment possibilities, according to an article published in Journal of Caffeine Research: The International Multidisciplinary Journal of Caffeine Science, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Neuralstem, Inc. announced that it received notification that the United States Patent and Trademark Office (USPTO) has upheld the patentability, without amendment, of all claims in U.S. Patent No. 5,753,506 and intends to issue a reexamination certificate in due course. This patent describes methods of culturing and expanding neural stem cells.
A new Tel Aviv University study suggests that a therapy that combines Virtual Reality and treadmill exercise dramatically lowers the incidence of falling among Parkinson's patients by changing the brain's behavior and promoting beneficial brain plasticity, even in patients with neurodegenerative disease.
Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced that the European Medicines Agency (EMA) has granted orphan drug designations for sialic acid for the treatment of hereditary inclusion body myopathy (HIBM) and recombinant human beta-glucuronidase for the treatment of mucopolysaccharidosis type 7.
Cancer cells defy the rules by which normal cells abide. They can divide without cease, invade distant tissues and consume glucose at abnormal rates.
› Verified 7 days ago
| Entity Name | Marshy Hope Family Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093897803 PECOS PAC ID: 6800840703 Enrollment ID: O20050303000324 |
News Archive
Women are more sensitive to the effects of cocaine and more susceptible to cocaine abuse than men. Cocaine's ability to disrupt a woman's estrus cycle may explain the sex differences in cocaine addiction, and new evidence that caffeine may be neuroprotective and able to block cocaine's direct effects on the estrus cycle reveals novel treatment possibilities, according to an article published in Journal of Caffeine Research: The International Multidisciplinary Journal of Caffeine Science, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Neuralstem, Inc. announced that it received notification that the United States Patent and Trademark Office (USPTO) has upheld the patentability, without amendment, of all claims in U.S. Patent No. 5,753,506 and intends to issue a reexamination certificate in due course. This patent describes methods of culturing and expanding neural stem cells.
A new Tel Aviv University study suggests that a therapy that combines Virtual Reality and treadmill exercise dramatically lowers the incidence of falling among Parkinson's patients by changing the brain's behavior and promoting beneficial brain plasticity, even in patients with neurodegenerative disease.
Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced that the European Medicines Agency (EMA) has granted orphan drug designations for sialic acid for the treatment of hereditary inclusion body myopathy (HIBM) and recombinant human beta-glucuronidase for the treatment of mucopolysaccharidosis type 7.
Cancer cells defy the rules by which normal cells abide. They can divide without cease, invade distant tissues and consume glucose at abnormal rates.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Meghan June Cleary, MSW, LCSW-C 813-1 Chesapeake Drive, Cambridge, MD 21613-1835 Ph: (410) 221-2266 | Mrs Meghan June Cleary, MSW, LCSW-C 813-1 Chesapeake Drive, Cambridge, MD 21613-1835 Ph: (410) 221-2266 |
News Archive
Women are more sensitive to the effects of cocaine and more susceptible to cocaine abuse than men. Cocaine's ability to disrupt a woman's estrus cycle may explain the sex differences in cocaine addiction, and new evidence that caffeine may be neuroprotective and able to block cocaine's direct effects on the estrus cycle reveals novel treatment possibilities, according to an article published in Journal of Caffeine Research: The International Multidisciplinary Journal of Caffeine Science, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Neuralstem, Inc. announced that it received notification that the United States Patent and Trademark Office (USPTO) has upheld the patentability, without amendment, of all claims in U.S. Patent No. 5,753,506 and intends to issue a reexamination certificate in due course. This patent describes methods of culturing and expanding neural stem cells.
A new Tel Aviv University study suggests that a therapy that combines Virtual Reality and treadmill exercise dramatically lowers the incidence of falling among Parkinson's patients by changing the brain's behavior and promoting beneficial brain plasticity, even in patients with neurodegenerative disease.
Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced that the European Medicines Agency (EMA) has granted orphan drug designations for sialic acid for the treatment of hereditary inclusion body myopathy (HIBM) and recombinant human beta-glucuronidase for the treatment of mucopolysaccharidosis type 7.
Cancer cells defy the rules by which normal cells abide. They can divide without cease, invade distant tissues and consume glucose at abnormal rates.
› Verified 7 days ago
Mrs. Mary June Mcginnis, MSW, LCSW-C Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 813-1 Chesapeake Drive, Cambridge, MD 21613 Phone: 410-221-2266 Fax: 410-221-2878 | |
Ms. Pamela Schulte, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 400 Muse St, Cambridge, MD 21613 Phone: 410-901-9500 Fax: 410-901-1388 | |
Mr. Felix Nathan, LCSW-C Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 813 Chesapeake Dr Ste 1, Cambridge, MD 21613 Phone: 410-221-2266 Fax: 410-221-2878 | |
Wendy Hare Simpson, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 813-1 Chesapeake Drive, Cambridge, MD 21613 Phone: 410-221-2266 Fax: 410-221-2878 | |
Jack L. Powell, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 310 Gay St, Lower Level, Cambridge, MD 21613 Phone: 410-228-7714 Fax: 410-228-8049 | |
Ms. Cheryl Ann Metzbower, Clinical Social Worker Medicare: May Accept Medicare Assignments Practice Location: 3 Cedar St, Cambridge, MD 21613 Phone: 410-228-7714 Fax: 410-228-8049 |